040-67 36 47 00
bd@jeevanscientific.com
Careers
Contact Us
About Jeevan
Company Profile
History & Milestones
Board of Directors
Executive Management
Services
BA/BE Studies
Clinical Trial Services
Pharmacovigilance Services
Facilities
Resources
Projects
Downloads
Service Brochures
List of validated methods
Corporate presentation
Subsidiary
Nayas Labs
News / Events
Investors & Relations
Financial Information
MOA and AOA
Annual Reports
Annual Returns
Results
Related Party Transactions
Postal Ballot
Corporate Governance
Details of Business
Board of Directors
Policies and Related Documents
Committees of board of directors
Investor Information
Shareholding Pattern
Investor Complaints
Corporate Governance
Scrutinizer Report
Notices of Board Meeting
Notices of Annual General Meetings
Forms for Processing Investor's Service Request
Contact Details
×
Close
Home
About Jeevan
Company Profile
History & Milestones
Board of Directors
Executive Management
Services
BA/BE Studies
Clinical Trial Services
Pharmacovigilance Services
Facilities
Resources
Projects
Downloads
Clinical Trial Services
Pharmacovigilance services
Corporate presentation Including BA/BE Services
Regulatory Inspections
List of validated methods
Subsidiary
Nayas Labs
News / Events
Investors & Relations
Reports
Share Holding Pattern
Prospectus
EGM Notice
Investors Help
Policies and Documents
Composition of Committees
Investors Complaints
Careers
Contact Us
Inverstors & Relations
Home
Inverstors & Relations
Investors Complaints
Investors Complaints
Statement of Investor Complaints for the Quarter Ended 30 September 2024
Statement of Investors Complaints for the Quarter Ened 30 June 2024
Satement of Investors Complaints for the Quartee Ended 31-March-2024
Satement of Investors Complaints for the Quartee Ended 31-December-2023
Satement of Investors Complaints for the Quarter Ended 30-September-2023
Satement of Investors Complaints for the Quarter Ended 30-June-2023
Statement of Investor Complaints for the Quarter Ended 31-March-2023
Statement of Investor Complaints for the Quarter Ended 31-December-2022
Statement of Investor Complaints for the Quarter Ended 30-September-2022
Statement of Investor Complaints for the Quarter Ended 30-June-2022
Statement of Investor Complaints for the Quarter Ended 31-March-2022
Statement of Investor Complaints for the Quarter Ended 31-December-2021
Statement of Investor Complaints for the Quarter Ended 30-September-2021
Statement of Investor Complaints for the Quarter Ended 30-June-2021
Statement of Investor Complaints for the Quarter Ended 31-March-2021
Statement of Investor Complaints for the Quarter Ended 31-December-2020
Statement of Investor Complaints for the Quarter Ended 30-September-2020
Statement of Investor Complaints for the Quarter Ended 30-June-2020
Statement of Investor Complaints for the Quarter Ended 31-Mar-2020
Statement of Investor Complaints for the Quarter Ended 31-Dec-2019
Statement of Investor Complaints for the Quarter Ended 30-Sep-2019
Statement of Investor Complaints for the Quarter Ended 30-June-2019
Statement of Investor Complaints for the Quarter Ended 31-Mar-2019
Statement of Investor Complaints for the Quarter Ended 31-Dec-2018
Statement of Investor Complaints for the Quarter Ended 30-Sep-2018
Statement of Investor Complaints for the Quarter Ended 30-June-2018
Statement of Investor Complaints for the Quarter Ended 31-Mar-2018
Statement of Investor Complaints for the Quarter Ended 31-Dec-2017
Statement of Investor Complaints for the Quarter Ended 30-Sep-2017
Statement of Investor Complaints for the Quarter Ended 30-June-2017
Statement of Investor Complaints for the Quarter Ended 31-Mar-2017
Statement of Investor Complaints for the Quarter Ended 31-Dec-2016
Statement of Investor Complaints for the Quarter Ended 30-Sep-2016
Statement of Investor Complaints for the Quarter Ended 30-Jun-2016
Statement of Investor Complaints for the Quarter Ended 31-Mar-2016
Statement of Investor Complaints for the Qurter Ended 31-Dec-2015